Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anixa Biosciences Inc ANIX

Healthcare Biotechnology
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well... see more

Recent & Breaking News (NDAQ:ANIX)

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

PR Newswire 10 days ago

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

PR Newswire 12 days ago

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

PR Newswire April 30, 2024

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

PR Newswire April 18, 2024

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

PR Newswire March 14, 2024

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

PR Newswire March 11, 2024

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

PR Newswire February 12, 2024

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

PR Newswire January 29, 2024

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

PR Newswire January 23, 2024

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Accesswire January 15, 2024

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

PR Newswire January 10, 2024

Anixa Biosciences to Present at Biotech Showcase 2024

PR Newswire December 14, 2023

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

PR Newswire December 6, 2023

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

PR Newswire December 6, 2023

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

PR Newswire November 27, 2023

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

PR Newswire October 31, 2023

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

PR Newswire October 23, 2023

Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial

PR Newswire October 13, 2023

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

PR Newswire October 3, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

PR Newswire September 19, 2023